George Karpouzas, MD, on How bDMARDS Prevent CV Events in Patients With RA

In this podcast, George Karpouzas, MD, talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs (bDMARDs) reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as their mechanism of action. Read the transcript here.

Additional Resource:

• Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ. Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high‐risk lesions [published online April 21, 2020]. Arthritis Rheumatol. https://doi.org/10.1002/art.41293

George A. Karpouzas, MD, is a professor of medicine at the University of California, Los Angeles, and chief of rheumatology at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Los Angeles, California.